BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hematopoietic cell
,
Rosiglitazone
,
rs4950928
,
BRAF
,
glucose metabolic process
,
Embryo
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
immunoproliferative disorders
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
IGHD
IGL
IGHA1
CCND1
IGHM
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PILON_KLF1_TARGETS_DN
PUJANA_BRCA1_PCC_NETWORK
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
heterocycle metabolic process
heterocyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Mature B cell lymphomas in c-myc-3'RR/p53+/- transgenic mice
Plasma cell tumor progression
Differences in TC molecular subtypes of multiple myeloma
Pre-osteocyte HOB-01 cells co-cultured with myeloma JJN3 cells
Multiple myeloma cells treated with A2A and Beta-2 Adrenergic Receptor agonists with dexamethasone
Explore Curated Studies Results
Literature
Most Relevant Literature
CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic feat…
Predominant IgG4 disease and concurrent early-stage rectal cancer.
Hydroxy-itraconazole pharmacokinetics is similar to that of itraconazole in immunocompromised patien…
Screening panels for detection of monoclonal gammopathies.
RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAM…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 S…
Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relaps…
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ